Tetrahydrofuran → HCID 178514081, compound
Reaction equation
[N:1]1([CH2:7][C:8]2[CH:22]=[CH:21][C:11]3[NH:12][C:13]([C:15]4[C:19]([NH2:20])=[CH:18][NH:17][N:16]=4)=[N:14][C:10]=3[CH:9]=2)[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.[N:23]1(C(Cl)=O)[CH2:28][CH2:27][O:26][CH2:25][CH2:24]1.C([N:35]([CH:38](C)C)CC)(C)C.C1C[O:44]CC1>>[N:23]1([N:20]([C:19]2[C:15]([C:13]3[NH:12][C:11]4[CH:21]=[CH:22][C:8]([CH2:7][N:1]5[CH2:6][CH2:5][O:4][CH2:3][CH2:2]5)=[CH:9][C:10]=4[N:14]=3)=[N:16][NH:17][CH:18]=2)[C:38]([NH2:35])=[O:44])[CH2:24][CH2:25][O:26][CH2:27][CH2:28]1Participants
5
Conditions
- Temperature
- 0 °C
Procedure
A mixture of 3-(5-morpholin-4-ylmethyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-ylamine (70 mg, 0.23 mmol), morpholine-4-carbonyl chloride (80 μl, 0.7 mmol) and diisopropylethylamine (170 μl, 0.92 mmol) in THF (2 ml) was stirred at 0° C. and then allowed to warm to room temperature over 16 h. The reaction was quenched by the addition of conc. aq. NH3 and then concentrated in vacuo. The residue was purified through preparative LC/MS to give 4-morpholinyl-N-[3-(5-morpholin-4-ylmethyl-1H-benzimidazol-2-yl)-1-H-pyrazol-4-yl]-urea as a white solid (35 mg). (LC/MS (basic method): Rt 2.28 min, [M−H+]− 415).
Workup
- temperatureto warm to room temperature over 16 h
- customThe reaction was quenched by the addition of conc. aq. NH3
- concentrationconcentrated in vacuo
- customThe residue was purified through preparative LC/MS
Sources & evidence
- ORD record
- ord-8d3218cd670041bbaf3f9ccfd9d12573
- Source dataset
- uspto-grants-2011_07
- Patent number
- US07977477B2
Reaction notes
Loading…